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doi:10.1Objectives: Rib fractures are a frequent traumatic injury associated with a relatively high morbidity. Currently,
the treatment of rib fractures is symptomatic. Since it has been reported that pulsed ultrasounds accelerates repair
of limb fractures, we hypothesized that the application of pulsed ultrasounds will modify the course of healing in
an animal model of rib fracture.
Methods: We studied 136 male Sprague–Dawley rats. Animals were randomly assigned to different groups of
doses (none, 50, 100, and 250 mW/cm2 of intensity for 3 minutes per day) and durations (2, 10, 20, and 28
days) of treatment with pulsed ultrasounds. In every subgroup, we analyzed radiologic and histologic changes
in the bone callus. In addition, we examined changes in gene expression of relevant genes involved in wound
repair in both control and treated animals.
Results: Histologic and radiologic consolidation was significantly increased by pulsed ultrasound treatment
when applied for more than 10 days. The application of 50 mW/cm2 was the most effective dose. Only the
100 and 250 mW/cm2 doses were able to significantly increase messenger RNA expression of insulin-like growth
factor 1, suppressor of cytokine signaling-2 and -3, and vascular endothelial growth factor and decrease monocyte
chemoattractant protein-1 and collagen type II-alpha 1.
Conclusions: Our findings indicate that pulsed ultrasound accelerates the consolidation of rib fractures. This
study is the first to show that pulsed ultrasound promotes the healing of rib fractures. From a translational point
of view, this easy, cheap technique could serve as an effective new therapeutic modality in patients with rib frac-
tures. (J Thorac Cardiovasc Surg 2011;141:1253-8)STrauma is the leading cause of death in patients younger than
40 years of age.1 Rib fractures (RFs) are reported in 4% to
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/Btrauma, and can cause pleuritic chest pain, pulmonary and/or
extrapulmonary visceral injuries, and infectious complica-
tions.1,2 In elderly persons, RFs are associated with
a relatively high morbidity and mortality, which may reach
up to 20% in case of severe pulmonary complications.3 The
number of broken ribs is directly related to bad outcome ow-
ing to extrapulmonary causes.4 Currently, themanagement of
RF is symptomatic, based on pain control,5 respiratory phys-
iotherapy, and specific treatment of associated complications.
Despite appropriate treatment of RF, functional disability of-
ten develops and can last several months, resulting in high
hospital, pharmaceutical, labor, and social costs.6 The physi-
ologic response to a bone fracture is the spontaneous initiation
of a sequence of events including inflammation followed by
a soft-callus formation, hard-callus formation, andbone repair
and remodeling.7 This process involves the gene activation
and synthesis of multiple growth factors that are expressed
in a defined time sequence and, in someways, it could be con-
sidered a recapitulation of endochondral bone development.8
Ultrasounds,widely used for diagnostic and therapeutic pur-
poses, are amajor therapeutic tool in physicalmedicine. Pulsed
ultrasound (PUS) is a form of noninvasive mechanical energy
that can be transmitted through the skin as a sound wave of
high pressure often exceeding 20 MHz. Several experimental
and clinical studies9,10 have shown that PUS with a 3-MHz
frequency and intensity of 30 mW/cm2 accelerates thediovascular Surgery c Volume 141, Number 5 1253
Abbreviations and Acronyms
BMP ¼ morphogenetic bone protein
CI ¼ confidence interval
IGF1 ¼ insulin-like growth factor 1
ISATA ¼ spatial average–temporal average
intensity
MMP3 ¼ matrix metallopeptidase 3
PCR ¼ polymerase chain reaction
PUS ¼ pulsed ultrasound
RF ¼ rib fracture
SOCS ¼ suppressor of cytokine signaling
VEGF ¼ vascular endothelial growth factor
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Sconsolidation of recent limb fractures, prevents complications
of fractures treated orthopedically, and accelerates the patient’s
return to his or her usual activities, thereby reducing costs and
improving quality of life. The effect of PUS on fracture
consolidation is dose- and time-dependent.11
To date, little is known of the molecular mechanisms un-
derlying the effects of PUS or whether these effects can be
extrapolated to other anatomic territories. This study repre-
sents the first evaluation of the effects of PUS on RF, in
an in vivo animal model.MATERIAL AND METHODS
This study was approved by the Institutional Review Board and Animal
Care Committee at the Hospital Universitario Dr. Negrin Las Palmas de
Gran Canarias, Spain.
Study Design
A total of 136male Sprague–Dawley rats weighing between 300 and 400
g were used under optimum stabling conditions and randomly assigned for
histologic and radiologic studies (n ¼ 88, phase I) and for genomic studies
(n ¼ 48, phase II). For phase I, animals were randomly distributed in 4
groups: a control group (n¼ 40) and 3 other groups receiving PUS at a doses
of 50 (n¼ 16), 100 (n¼ 16), and 250 mW/cm2 (n¼ 16) of spatial average–
temporal average intensity (ISATA). Then, each group was divided into
a function of time in 2, 10, 20, and 28 days for controls (n¼ 10 by subgroup)
and for each group of PUS (n¼ 4 by subgroups). For phase II, animals were
randomly distributed in control (n¼ 12), 50 (n¼ 12), 100 (n¼ 12), and 250
mW/cm2 ISATA (n¼ 12), and each group was subdivided in 2 subgroups: 10
and 28 days (n ¼ 6 in each subgroup).
PUS treatment. PUS was applied through a Sonopuls 490 sonograph
(Enraf-Nonius BV, Rotterdam, The Netherlands). We used a head of 3
MHz, an area of effective radiation of 0.5 cm2, a beam nonuniformity ratio
of 6 (which represents the ratio of the highest intensity in the field to the av-
erage intensity), and an ISATA of 0.5W/cm
2 (which represents the maximum
value occurring in time of the spatially averaged intensity), using pulses of 1
ms every 9 ms of pause when applied to 10% (50 mW/cm2 ISATA) or 2-ms
pulse every 8ms of pause when applied to 20% (100mW/cm2 ISATA) and 5-
ms pulse with 5 ms of pause when applied to 50% (250 mW/cm2 ISATA).
ISATA, the spatial average–temporal average intensity, represents the total
power in the beam divided by the beam area and averaged over the pulse
repetition period. When evaluated at the transducer face, the head slipped
in an area of skin of about 1.5 cm2. The total time of application by sitting
on each animal was 3 minutes per day in a single session of therapy.1254 The Journal of Thoracic and Cardiovascular SurExperimental model. Animals were anesthetized by subcutaneous
injection of 0.25 mg/kg of medetomidine and an intraperitoneal injection
of 50 mg/kg of ketamine, intubated with an orotracheal tube, and mechan-
ically ventilated (Servo 900; Siemens AG, Munich, Germany). A left thora-
cotomy was performed and a fragment of 0.5 cm of 2 adjacent ribs was
removed. After all surgical procedures, animals received a subcutaneous in-
jection of 0.25 mg/kg of atipamezole. All animals were treated with 0.025
mg/kg per 12 hours subcutaneously of buprenorphine during the following
72 hours. After 24 hours of surgery, the treated animals received PUS daily
until being put to death. A new thoracotomy was performed at 2, 10, 20, and
28 days. The bone callus was isolated and included in formaldehyde 1% for
histologic study or was immediately snap-frozen in liquid nitrogen and
stored at 80C for genomic studies. Animals were humanely killed in
a chamber of carbon dioxide.
Histologic and radiologic evaluations. The bone callus speci-
mens were serially sliced and processed in the usual manner, embedded in
paraffin, then cut at 10-mm thickness, stained with hematoxylin and eosin,
and examined under a light microscope. A pathologist (J.C.R.) blinded to
the experimental history of the bone specimens, performed the pathologic
studies. Random sections of the callus from each animal were examined
with particular reference to the presence and distribution of inflammatory
infiltrate and extracellular matrix mineralization and classified in 3 cate-
gories: inflammatory, repair, and remodeling.
We performed a chest radiograph on all animals (Siemens Mobilett II;
Siemens, Erlangen, Germany) at 55 KV and 3.2 mAs immediately after
the operation and just before animal death. Radiologic images were evalu-
ated by a radiologist (M.M.T.) blinded to the experimental history of the
specimens. Images were classified in 3 categories: lack of callus, callus
emerging, and callus formed.
Analysis of gene expression by quantitative real-time
polymerase chain reaction (PCR). Total RNA was isolated
from bone callus with TRIzol reagent (Invitrogen, Carlsbad, Calif) follow-
ing manufacturer’s instructions. For the purpose of this study, we examined
the expression of several genes involved in bone repair and remodeling,
such as morphogenetic bone protein-2 (BMP), collagen type II-alpha 1,
insulin-like growth factor 1 (IGF1), monocyte chemoattractant protein-1,
matrix metallopeptidase 3, transforming growth factor beta, vascular endo-
thelial growth factor (VEGF), polymerase II polypeptide A, and for the first
time, suppressor of cytokine signaling (SOCS)-2 and SOCS3. The cDNA
synthesis was achieved by diluting 2 mg of RNA in a final volume of 20
ml with random primers, deoxyribonucleotides, and Moloney murine leuke-
mia virus reverse transcriptase (Promega Corporation, Madison, Wis) for 1
hour at 37C. Primers were designed using Primer3 software.12 Real time
PCR reactions were performed using LightCycler–FastStart DNA Master
SYBR Green I (Roche Applied Science, Mannheim, Germany). Serially di-
luted samples containing pooled complementary DNAs from each animal
were used for the standard curves. Achievement of a single PCR product
was confirmed by agarose gel electophoresis.
Statistical Analysis
Data are expressed as group mean SD or median, as appropriate. Com-
parisons among the categorical variables were assessed with the Fisher’s
exact test and c2. Odds ratio with 95% of confidence interval (CI) were de-
termined. The differences in the gene expression activity were tested with
the Mann–Whitney U test. Data management and statistical analysis were
performed using the statistical package SPSS 14.0 (SPSS, Inc, Chicago, Ill).RESULTS
Postoperative Outcome
Two animals from the control group and 1 animal from the
50 mW/cm2 group (phase I) died during the first 24 hours af-
ter the operation owing to unexpected surgical complicationsgery c May 2011
FIGURE 1. Radiologic and histologic findings after pulsed ultrasound treatment of rib fractures. A, No radiologic callus (arrow) was observed in 1 repre-
sentative control animal at 28 days of treatment. B, Radiologic bone callus (arrow) and periosteal reaction in 1 representative animal treated with 50 mW/cm2
at 28 days. C, Inflammatory infiltrate (arrow) and hemorrhage in 1 representative control animal at 28 days (original magnification 103). D, Bone remodeling
in 1 representative animal treated with 50 mW/cm2 where osteoclast cells (arrow) can be observed at 28 days (original magnification 403).
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Sand were removed from further analyses. The rest of the
animals had a good postoperative outcome without signs
of respiratory insufficiency or flail chest.
Histologic Findings
Histologic features revealed that 26.3% of controls and
66% of PUS-treated animals were undergoing repair and
remodeling (P ¼ .001) (Figure 1). The odds ratio for callus
formation in animals treated was 5.4 (95% CI, 2.1–13.9).
During the first 10 days after surgery, only 41.6% of the an-
imals treated with PUS and none of the control animals had
calluses undergoing repair or remodeling. In contrast, when
animals were treated for more than 10 days, 91.3% of the
PUS group and 55.5% of controls were undergoing repair
and remodeling (P ¼ .010). Repair or remodeling was ob-
served in 73.3% of animals treated with 50 mW/cm2,
68.8% with 100 mW/cm2, and 56.3% with 250 mW/cm2
(Figure 2, A). This was a significant improvement over con-
trols (P¼ .003 for eachgroup), butweobservedno significantThe Journal of Thoracic and Cardifferences between the treatment groups (P ¼ .580). When
we pooled the animals, 71% of animals treated with 50 and
100 mW/cm2 were undergoing repair and remodeling, as
compared with 56.3% of the animals in the 250 mW/cm2
group (P ¼ .027). The odds ratio for callus formation
was 7.7 (95% CI, 1.9–29.7) for 50 mW/cm2, 6.1 (95% CI,
1.7–22.1) for 100 mW/cm2, and 3.6 (95% CI, 1.0–12.2) for
250 mW/cm2.
Radiologic Findings
An incipient or formed bone calluswas observed in 26.3%
of control animals as compared with 59.6% of treated
animals (P¼ .001). The odds ratio for callus formation in an-
imals treated was 4.1 (95% CI, 1.6–10.4). When we applied
PUS for less than 10 days, only 29.1% of treated animals and
none of the control group showed callus formation. In con-
trast, 91.3% of animals treated for more than 10 days and
55.5% of the control group had calluses (P ¼ .028). Callus
or incipient bone formed in 73.3% of animals treated withdiovascular Surgery c Volume 141, Number 5 1255
FIGURE 2. Histologic and radiologic bone consolidation with different doses of PUS. A, Histologic examination revealed that bone consolidation was
higher in the pooled PUS treatment group than in the control group (66% vs 26.3%; P ¼ .001). Consolidation at different doses of PUS was better than
in the control groups (P ¼ .003 for each doses subgroup), although this improvement was lower with 250 mW/cm2 than with lower doses (50 and 100
mW/cm2 ISATA; P ¼ .027). B, Radiologic analysis revealed that incipient or formed bone callus was higher in the pooled PUS treatment group than in
the control group (59.6% vs 26.3%; P¼ .001). Consolidation at different doses of PUS was better than in control group (P¼ .003 for each doses subgroup),
although this improvement was lower with 250 mW/cm2 than with lower doses (50 and 100 mW/cm2 ISATA; P¼ .027). PUS, Pulsed ultrasound; ISATA, spatial
average–temporal average intensity.
TABLE 1. Effects of total PUS treatment on transcriptional activity in
the callus from rib fractures
Gene Days of treatment Control PUS P*
IGF1 10 1.00  0.19 1.47  0.37 .008
28 1.00  0.14 1.72  0.43 .003
TGFb1 10 1.00  0.20 1.07  0.23 .373
28 1.00  0.51 1.22  0.35 .322
COL2a1 10 1.00  0.61 0.99  0.85 .899
28 1.00  1.13 0.93  1.62 .563
VEGFa 10 1.01  0.26 1.17  0.46 .703
28 1.00  0.20 1.62  0.69 .039
MMP3 10 1.00 (0.71–2.35) 0.69 (0.19–4.35) .378
28 1.00 (0.56–5.41) 0.78 (0.19–3.28) .635
BMP2 10 1.00  0.19 0.88  0.21 .227
28 1.00  0.29 1.15  0.32 .283
SOCS2 10 1.00  0.67 1.72  0.55 .019
28 1.01  0.63 1.98  0.55 .010
SOCS3 10 1.00  0.95 1.06  1.00 .799
28 1.01  0.65 1.70  0.93 .137
MCP-1 10 1.00  0.91 0.71  0.70 .181
28 1.00  0.26 0.99  0.51 .741
Messenger RNA expression of genes normalized to polymerase II polypeptide A and
presented as fold-change relative to control. Data are representative of 3 independent
experiments and presented as mean  SD. MMP3 is expressed as median (minimum
and maximum). PUS, Pulsed ultrasound; IGF1, insulin-like growth factor 1; TGFb,
transforming growth factor beta; Col2a1, collagen type II-alpha 1; VEGFa, vascular
endothelial growth factor alpha;MMP3,matrix metallopeptidase 3; BMP2,morphoge-
netic bone protein 2; SOCS, suppressor of cytokine signaling; MCP-1, monocyte
chemoattractant protein-1. *The P value estimates the differences between the control
group and all PUS treatment groups and was computed using the Mann–Whitney
U test.
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S50mW/cm2, 68.8%with 100mW/cm2, and 37.5%with 250
mW/cm2 (Figure 2, B). This was a significant radiologic im-
provement over controls (P¼ .003 for each group), although
we did not observe significant differences between the treat-
ment groups (P ¼ .083). However, significant differences
were found between the treatment groups whenwe evaluated
the number of incipient and formed calluses for 50 and 100
mW/cm2 combined (71%) versus 250 mW/cm2 (37.5%)
(P ¼ .027). The odds ratio for callus formation was 7.7
(95% CI, 1.99–29.75) for 50 mW/cm2, 6.16 (95% CI,
1.71–22.15) for 100 mW/cm2, and 1.68 (95% CI, 0.48–
22.15) for 250 mW/cm2.
Gene Expression
When we grouped all animals treated with PUS versus
controls, we observed a significant increase in the expression
of IGF1, SOCS2, and VEGFa (Table 1). When we evaluated
the dose-dependent effects with regard to the time of treat-
ment, we observed that 100 mW/cm2 significantly increased
IGF1 expression at 10 and 28 days and SOCS2 at 28 days
and decreased monocyte chemoattractant protein-1 at 28
days. Similarly, 250 mW/cm2 increased SOCS3 expression
at 10 days and SOCS2, IGF1, and VEGFa at 10 and 28
days and decreased the expression of COL2a1 at 28 days.
No significantly variations were observed with 50-mW/
cm2 PUS dose (Figure 3, A and B).
DISCUSSION
The major finding of our study was that PUS was able to
accelerate the consolidation of RF. Our study showed for the
first time that the histologic and radiologic consolidation of
RF is significantly improved over the natural healing process
when animals are treated with PUS. Several experimental
and clinical studies have previously examined the benefits1256 The Journal of Thoracic and Cardiovascular Surof PUS for fracture repair of limbs,11 but no studies have
reported the use of PUS in RF yet. Currently, there are no
effective treatments to alter the functional complications
of RF, which often last for several months and confer
a high cost. As a result, some authors have suggested thatgery c May 2011
FIGURE 3. Messenger RNA expression of IGF1, VEGF, SOCS2, and SOCS3. A, At 10 days, treatment with 100 mW/cm2 increased IGF1 (P ¼ .004) and
treatment with 250 mW/cm2 increased SOCS3 (P ¼ .046), SOCS2 (P ¼ .045), IGF1 (P ¼ .003), and VEGFa (P ¼ .032). No significant variations were ob-
served with 50 mW/cm2 after 10 days of treatment. Data are representative of 3 independent experiments and error bars indicate standard deviations from the
mean. *Statistically significantly differences between control and PUS treatment groups. B, At 28 days, animals treated with 100 mW/cm2 ISATA group had
significantly higher levels of IGF1 (P ¼ .006) and SOCS2 (P ¼ .018). Animals treated with 250 mW/cm2 showed an increase of SOCS2 (P ¼ .045), IGF1
(P ¼ .006), and VEGFa (P ¼ .028). No significant variations were observed with 50 mW/cm2 after 28 days of treatment. Data are representative of 3 inde-
pendent experiments. Error bars indicate standard deviations from themean. *Statistically significantly differences between control and PUS treatment group.
PUS, Pulsed ultrasound; ISATA, spatial average–temporal average intensity; IGF1, insulin-like growth factor 1; VEGF, vascular endothelial growth factor;
SOCS, suppressor of cytokine signaling.
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large individual and social profits.13
It has been previously reported that longer duration of
treatment is more effective for consolidation of fractures of
inferior limbs in rats.14 Our study found that animals treated
for more than 10 days had 5 times greater bone callus forma-
tion. This suggests that the rib repair induced by PUS re-
quires a longer duration of treatment to accelerate the
progression from the inflammatory phase to the repair phase.
In our study, PUS was applied for just 3 minutes per day,
which is much less time than the 15 minutes15 or 20 min-
utes14 often described for treatment of lower limb fractures
in rats. This time does not appear to have limited the effec-
tiveness of PUS on the RF, thus greatly shortening the treat-
ment time and making it more tolerable and easier to apply.
We observed that the consolidation decreased with the in-
creasing intensity applied. In this sense, our data are consis-
tent with those obtained for lower extremity fractures,
in which the best results were obtained with 30 mW/cm2.
It is unlikely that this minor effect observed with 250 mW/
cm2 on the RF consolidation is due to thermal damage, as
it has been postulated with much higher intensities.16
The mechanism by which PUS proves beneficial is still
largely unknown. There are evidences that PUS produces
an increasing cellular activity.7 Several in vitro experiments
have demonstrated that PUS treatment is capable of inducing
the activation of several genes. A recent study17 with a crop
of bone marrow cells from rats has been able to demonstrate
that PUS increased the expression of genes involved in
osteoblast proliferation and differentiation such as IGF1.
Whether these effects occur in vivo, appear during pro-
longed PUS treatment, or relate to the therapeutic effect on
the same fractures is still unclear. Our study confirmed that
PUS induced significant changes in the expression of IGF1The Journal of Thoracic and Carand VEGFa and showed for the first time that PUS induced
changes in SOCS2 and SOCS3 gene expression in early and
late stages of the regeneration of RF. IGF is the most abun-
dant growth factor in the bone matrix and a powerful stimu-
lator of osteogenesis.18 IGF1 is produced by osteoblasts and
stimulates bone formation by inducing cell proliferation,
osteoblast differentiation, biosynthesis of collagen type I,
osteoclastogenesis, and interaction osteoblast–osteoclasto.19
Generally IGF1 acts as a mitogenic factor that is widely dis-
tributed in the soft early stages in fracture callus repair.20 Its
expression increases significantly after the third day, reach-
ing a peak within 10 days, and then declines gradually until
day 21 in femur fracture from rats.21 Furthermore, new blood
vessels are known to form during the inflammatory stage of
repair, and in vitro cell studies have demonstrated that PUS
exposure increases the VEGF expression in osteoblast.
VEGF is the major regulator both in vitro and in vivo of an-
giogenesis in various pathophysiologic processes. This may
stimulate angiogenesis, which is both a key component in
early bone repair and a necessary precursor to endochondral
ossification.11,17 We have observed a significant increase in
the expression of IGF1 and VEGFa in late stages of RF
repair induced by PUS.
On the other hand, both SOCS2 and SOCS3 negatively
regulate the signal transduction of several proinflamatory
cytokines and IGF1.22 SOCS2(/) mice showed increased
longitudinal skeletal growth associated with deregulated
growth hormone/IGF1 signaling. Recently, it has been
shown that physiologic levels of SOCS2 negatively regulate
bone formation and endochondral growth.23 Accordingly,
our results suggest that the increase of SOCS2 and SOCS3
expressions are associated with worst RF consolidation in-
duced by PUS. In this sense, the highest dose increases the
expression of IGF1, VEGF, SOCS2, and SOCS3, suggestingdiovascular Surgery c Volume 141, Number 5 1257
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uation of inflammation and tissue damage in response to
PUS doses24 and decreasedCOL2a1 expression. In addition,
it has been observed that doses of 30 mW/cm2 promote de-
position of calcium and the synthesis of collagen matrix
mesh that supports bone mineralization, whereas exposure
to higher intensities of ultrasound 120 mW/cm2 produces
a lower deposition of calcium.25 A deep molecular knowl-
edge also helps to understand why the worst results in the
consolidation of RF in our study were found in animals
treated with higher PUS doses, and therefore higher doses
must be avoided to treat RF, although we have not elucidated
the mechanisms by which PUS is beneficial.
The main limitation encountered by our study was the dif-
ficulty to evaluate the possible analgesic effects of PUS in
rats; therefore, we will have to wait for the clinical studies
in humans to be able to determine this issue. An ongoing
multicenter randomized clinical trial (supported by SEPAR,
the Spanish Society of Neumology and Thoracic Surgery) is
designed to evaluate further the effects of PUS in patients
with rib fractures.
In conclusion, this is the first time that the beneficial effect
of PUS on the consolidation of RF has been demonstrated.
The healing rate of callus formation was greater than in con-
trols and the ongoing clinical studies will confirm whether
there is actual benefit.
We thank Yanira Brito Godoy, Pedro LLontop Santisteban, Dr
Nicola´s Dı´az Chico, Dr Ricardo Chirino Godoy, and Dr Jose´ Carlos
Rodrı´guez Pe´rez for their support.
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